000			01658 a2200457 4500
005			20250516140034.0
264		0	_c20131021
008			201310s 0 0 eng d
022			_a1875-533X
024	7		_a10.2174/0929867311320170008 _2doi
040			_aNLM _beng _cNLM
100	1		_aStocco, G
245	0	0	_aPharmacogenomic approaches for tailored anti-leukemic therapy in children. _h[electronic resource]
260			_bCurrent medicinal chemistry _c2013
300			_a2237-53 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAlkaloids _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBenzamides _xtherapeutic use
650	0	4	_aChild
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aHepatic Veno-Occlusive Disease _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aMercaptopurine _xtherapeutic use
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aNucleotides _xtherapeutic use
650	0	4	_aPharmacogenetics
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aThioguanine _xtherapeutic use
650	0	4	_aVincristine _xtherapeutic use
700	1		_aFranca, R
700	1		_aVerzegnassi, F
700	1		_aLondero, M
700	1		_aRabusin, M
700	1		_aDecorti, G
773	0		_tCurrent medicinal chemistry _gvol. 20 _gno. 17 _gp. 2237-53
856	4	0	_uhttps://doi.org/10.2174/0929867311320170008 _zAvailable from publisher's website
999			_c22551327 _d22551327